Skip to main content

Monopar Therapeutics Inc (MNPR) Insider Trading

In the last 90 days, 5 Monopar Therapeutics Inc (MNPR) insiders reported no open-market purchases and 7 sales totaling $4,527,911. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Nov 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Nov 4, 2026Kim R TsuchimotoCorporate insiderSale4,090$70.92$290,062
Nov 2, 2026Raymond AndersonCorporate insiderSale3,142$68.35$214,747
Oct 1, 2026Christopher M StarrCorporate insiderSale8,400$78.50$659,387
Sep 24, 2026Chandler RobinsonChief Executive OfficerSale29,056$88.00$2,556,850
Aug 26, 2026Patrice RiouxCorporate insiderSale1$111.26$111.26
Aug 26, 2026Kim R TsuchimotoCorporate insiderSale4,090$111.39$455,567
Aug 25, 2026Raymond AndersonCorporate insiderSale3,142$111.77$351,189

Common questions

MNPR insider trading FAQ

Are MNPR insiders buying or selling?
Over the last 90 days, MNPR insiders were net sellers, reporting $0.00 of open-market purchases and $4,527,911 of sales.
When was the last MNPR insider purchase?
No open-market insider purchase of Monopar Therapeutics Inc stock was reported in the last 90 days.
Where does MNPR insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Monopar Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.